Short-Term Effects of Equol (Soy metabolite) Supplementation on Blood Vessel Function in Postmenopausal Women with and without Chronic Kidney Disease
This study is looking at the short-term effect of equol supplementation (1, 2, and 3 hours after ingestion) on blood vessel function in women with and without chronic kidney disease. Equol is a dietary supplement. Equol is a metabolite of soy that is produced by the gut microbiome.
Why this Research Matters
-One screening visit (1.5 hours) and two testing visits (each 5 hours) -Testing visits will include a blood draw and non-invasive testing of blood vessel function -All visits will take place at CU Anschutz As a volunteer, you will receive the following information about your health: -Blood Lipids Screening -Blood Pressure Screening -Resting ECG -Physical Examination Compensation provided. For more information, please contact: rachael.reddin@cuanschutz.edu
What to Expect
Study visits will include a blood draw and non-invasive testing of blood vessel function. As a volunteer, you will receive blood lipids screening, blood pressure screening, resting ECG, and physical examination.
Study Duration
One screening visit (1.5 hours) and two testing visits (each 5.5 hours). All visits will take place at CU Anschutz.
Who can Participate
We are looking for postmenopausal women (aged 50-69 years) that are generally healthy and free from hypertension OR have chronic kidney disease, that are non-smokers and free from advanced CKD requiring chronic dialysis.
Study ID
Protocol Number: 23-0070
Compensation Information
Meet the Team
Principal Investigator